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Like calcium and fluorine, lead has an affinity
for maturing bone. Calcified tissues, such as
bone and teeth, are the principal sites for lead
storage in adults and children, and bone rep-
resents more than 90% of the total body bur-
den of lead in adults (Barry 1975; Schroeder
and Tipton 1968). Once lead is incorporated
into the crystalized architecture of bone, not
only does it become a dormant structural
component of the osseous matrix until osteo-
clastic activity can release it into the circula-
tion (Klein and Wiren 1993; Rabinowitz
1991) but it also may be affected by bone
resorption (Tsaih et al. 2001). Although the
half-life of lead in the human skeleton is not
well quantified, it could range into decades
(Barry 1975; Rabinowitz et al. 1976;
Steenhout 1982). Unlike the long residence
time of lead in bone, the half-life of lead in
blood is only 30 days (Rabinowitz 1991).
Given the low mean bone turnover rates in
adults (2–4% in persons ≥ 30 years of age),
bone lead stores in adults represent years of
accumulated exposure (Rabinowitz 1991).
Consequently, skeletal sources of lead could
be responsible for elevated blood lead (PbB)
levels, even when lead exposure ended years
ago (Rabinowitz 1998). In contrast to bone
lead stores, lead in the circulation is not only
an indicator of past exposure as lead is
released from bone but of current environ-
mental exposure as well (Hu et al. 1998).
The flux of lead into blood may be con-
nected not only with normal bone turnover,
but with periods of rapid bone metabolism as
well. It has been suggested that PbB levels
could be increased during pregnancy, lacta-
tion, mineral deficiencies from diet, and some
disease conditions, such as hyperthyroidism
and osteoarthritis (Gulson et al. 1995; Smith
et al. 1996). It has also been reported that lead
exposure may be associated with pediatric
dental caries (Moss et al. 1999). Because it
appears that accelerated bone turnover or
mineral loss can contribute to increased lead
in blood, it seems biologically plausible that
bone loss from advanced periodontal disease
would be associated with increased PbB levels.
Periodontal disease is characterized by
periods of active destruction of the periodon-
tium followed by periods of protracted inac-
tivity. This waxing and waning nature of
periodontal disease is insidious and often
asymptomatic among many individuals. The
chronic progression of the disease leads to
irreversible alveolar bone loss that may
advance to pocket depth formation and
increase loss of clinical attachment of the
tooth. The creation of a diseased periodontal
pocket is the result of soft-tissue inflamma-
tion with inferiorly progressing alveolar bone
loss (Figure 1). As the diseased pocket
advances apically, tooth attachment is dam-
aged and the supporting alveolar bone is
destroyed, which increases the likelihood of
tooth loss. Pocket depth may increase or
decrease with advancing attachment loss in
chronic periodontitis. For affected posterior
teeth, significant attachment loss will lead to
the destruction of alveolar bone between a
tooth’s roots, forming a dental furcation.
Although there is no consistent pattern to the
development of advanced periodontal bone
loss, an individual must develop significant
posterior attachment loss to acquire dental
furcations. The most current epidemiologic
findings from the United States indicate that
53% of adults 30–90 years of age have at least
one dental site with ≥ 3 mm of loss of attach-
ment, compared to nearly 64% who have ≥ 3
mm of pocket depth (Albandar et al. 1999).
It is also well known that periodontal disease
increases with age, that it is more prevalent in
males, and that it is associated with smoking
and some socioeconomic indicators.
Recent U.S. population findings indicate
that older adults have higher PbB levels com-
pared to younger adults, and current smokers
are more likely to have higher PbB levels com-
pared to nonsmokers (Pirkle et al. 1998).
Moreover, cross-sectional results from the
Normative Aging Study (a population-based
study of men) indicate that bone lead concen-
trations are associated with age and smoking
history and that increases in bone lead directly
correspond to increases in PbB levels (Hu et al.
1996). Because age, smoking, and periodontal
disease are significantly interrelated, studies
investigating PbB levels should adjust for fac-
tors including advanced periodontal bone loss.
In this study, we examined the relation-
ship between PbB levels and intra-oral bone
loss associated with measurable dental clinical
parameters indicative of periodontal disease.
We hypothesized that moderate to severe peri-
odontal bone loss may be a contributory
source of lead in the circulation and that it is
associated with increased PbB levels. Using a
nationally representative sample, we examined
the association of periodontal bone loss with
increased PbB levels while controlling for con-
founding influences such as age and smoking. 
Methods
Study population. We used data from 10,033
persons who participated in the Third National
Health and Nutritional Examination Survey
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An association between bone disease and bone lead has been reported. Studies have suggested that
lead stored in bone may adversely affect bone mineral metabolism and blood lead (PbB) levels.
However, the relationship between PbB levels and bone loss attributed to periodontal disease has
never been reported. In this study we examined the relationship between clinical parameters that
characterize bone loss due to periodontal disease and PbB levels in the U.S. population. We used
data from the Third National Health and Nutritional Examination Survey (NHANES III),
1988–1994, for the analyses. A total of 10,033 participants 20–69 years of age who completed a
periodontal examination and had whole blood tested for lead were examined. Four types of peri-
odontal disease measures were used to indicate oral bone loss: periodontal pocket depth, attach-
ment loss extent, attachment loss severity, and the presence of dental furcations. We found that
dental furcations were the best periodontal bone loss indicator for PbB levels (p = 0.005) in a mul-
tivariate linear regression model adjusting for sex, age, race/ethnicity, educational attainment,
poverty status, smoking, and age of home. Furthermore, after additional modeling, we found a
smoking and dental furcation interaction (p = 0.034). Subsequent stratified analyses indicated that
current and past smoking is an effect modifier for dental furcations on PbB levels. These findings
indicate that increased PbB levels may be associated with advanced periodontal bone loss, particu-
larly among people with a history of smoking. Key words: alveolar bone loss, blood lead, lead,
NHANES, periodontal disease, smoking. Environ Health Perspect 110:997–1002 (2002). [Online
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(NHANES III), 1988–1994. Conducted by
the National Center for Health Statistics
(NCHS) of the Centers for Disease Control
and Prevention (CDC), NHANES III uti-
lized a complex, highly stratified, multistage
probability design capable of producing a
nationally representative sample. Details of
the sample design and methods used in
obtaining informed consent from study par-
ticipants have been described elsewhere
(CDC 1994). NHANES III oversampled
individuals who were ≤ 6 years of age, > 60
years of age, Mexican Americans, and non-
Hispanic blacks. This was done to enhance
the reliability of prevalence estimates for these
groups in the noninstitutionalized civilian
population of the United States. 
A total of 17,030 participants ≥ 20 years
of age who had completed the home inter-
view component of NHANES III were exam-
ined. We excluded 3,358 individuals ≥ 70
years of age because of low participation rates
(< 50%) in completing the sequence of inter-
viewing, PbB testing, and having enough
teeth to complete a periodontal examination.
We then excluded 10 individuals who did not
have PbB test results. From the remaining
group, we excluded 1,721 persons who were
edentulous or had < 6 natural teeth, and we
excluded 1,903 additional individuals who
did not have complete periodontal exam
information. This yielded an analytical sam-
ple of 10,033 individuals for our study. 
For this study, demographic data were
obtained from a household interview ques-
tionnaire, and participants had a standardized
oral health exam and venipuncture at a mobile
examination center. The dental examinations
were conducted by trained dentists who were
periodically calibrated by the survey’s expert
dental examiner, and inter-rater reliability was
considered to be good between the survey
examiners and the reference examiner (Drury
et al. 1996; Winn et al. 1999). PbB levels
were measured by graphite furnace atomic
absorption spectrophotometry (GFAAS) and
are described elsewhere (Pirkle et al. 1998).
Covariate selection. For this analysis, we
included known risk factors for PbB as well as
periodontal disease. Race/ethnicity was cate-
gorized as Mexican American, non-Hispanic
black, non-Hispanic white, and other.
Individuals who were identified as “other”
were included in the total population esti-
mates but not in the regression analyses.
Poverty status was dichotomized as either
≤ 130% of the federal poverty level or
> 130% and was calculated by taking the
quotient of total family income and the
adjusted federal poverty income threshold.
Educational attainment was dichotomized as
either not completing high school or as hav-
ing graduated from high school. Age and sex
were also analyzed. Cigarette smoking status
was categorized as either current smoker, for-
mer smoker, or never smoked. Persons who
reported that they had smoked at least 100
cigarettes (approximately five packs) in their
lifetime but no longer smoked cigarettes were
classified as former smokers. Age of home, a
known risk factor for elevated PbB, was cate-
gorized into three construction periods: before
1946, 1946–1973, and after 1973. The age of
home categorization was established by the
NCHS and publicly released in this format.
Residential paint containing up to 50% lead
was in widespread use through the 1940s; lead
usage in residential paint declined thereafter
and was banned in 1978 (CDC 1997). 
Although we did not classify participants
according to their periodontal disease status,
we did identify certain clinical characteristics
that could constitute disease when used with
radiographs in a more appropriate diagnostic
setting. These indicators of disease are peri-
odontal attachment loss, pocket depth, and
root furcations. Periodontal measurements
for both attachment loss and pocket depth
were made at the mid-facial and mesial facial
interproximal sites on each permanent tooth
in two randomly selected quadrants (i.e., one
maxillary and one mandibular). The evalua-
tion for the presence of dental root furcations
was made only on the maxillary second bicus-
pid, first and second molars, and the
mandibular first and second molars in the
same randomly selected quadrants. Detailed
information about the NHANES III oral
health component protocol and measurement
issues have been described elsewhere (CDC
1994; Drury et al. 1996).
We characterized attachment loss by two
methods: an extent index and a mean bone
loss score. For the disease extent index of
attachment loss, the number of dental sites
affected by clinical attachment loss was
summed and divided by the number of dental
sites evaluated. This ratio was categorized into
four groups: 0–15% of the dentition affected,
16–30% of the dentition affected, 31–45%
of the dentition affected, and ≥ 46% of the
dentition affected. Clinical attachment loss,
as an indicator of past periodontal disease,
was defined as sites that had experienced a
minium of 2 mm of measured loss. This cri-
teria was established to reflect a previously
published extent and severity attachment loss
index (Carlos et al. 1986). For mean bone
loss, attachment loss measured in millimeters
at each dental site was summed and divided
by the number of sites examined to produce a
mean alveolar bone loss score. This score was
categorized into three groups: < 1.5 mm of
mean bone loss, 1.5–2.5 mm of mean bone
loss, and > 2.5 mm of mean bone loss.
Periodontal pocket depth was expressed as
a dichotomous variable indicating that at least
one dentate site had a pocket depth of ≥ 5 mm.
Periodontal probing depths in the range of 5
mm will generally classify an individual as a
chronic periodontitis case with moderate
destruction (Anonymous 2000). Both partial
and complete furcal bony defect types were
grouped to form a dichotomous variable that
identified an individual as having either none
or at least one dentate site affected by a dental
furcation.
Data analysis. All statistical analyses were
performed with SUDAAN, a software package
specifically designed to accommodate complex
sample surveys (Shah et al. 1996). We used
sample weights to account for the unequal
probability of selection and nonresponse of the
study participants to produce estimates, regres-
sion coefficients, and related standard errors.
We used the GEOMETRIC option within
SUDAAN to calculate mean PbB levels. We
assessed potential prevalence differences of
PbB levels ≥ 10 µg/dL within the defined risk
categories by calculating t statistics using a lin-
ear contrast procedure in SUDAAN.
We used linear regression models to esti-
mate unadjusted and adjusted coefficients
(coef.) and related SEs with statistical signifi-
cance established at p < 0.05. Because PbB
levels were not normally distributed, we used
the log10 transformation of the PbB levels as
the dependent variable. Except for age, all
independent variables were modeled categori-
cally as previously described. Age in years was
analyzed as a continuous variable. For the
multivariate linear regression analysis, we used
nonautomatic stepwise regression modeling to
assess the relationships between the covariates.
Linear multivariate models were determined
by covariate exclusion with criteria for inclu-
sion set at p < 0.05. We modeled the peri-
odontal indicators independently with the
social/demographic and behavior covariates to
examine relationships among the independent
variables. To avoid potential multicollinearity
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Figure 1. Schematic showing the progression of
alveolar bone loss (not drawn to scale). A, Healthy
periodontium with nondiseased pocket depth and
no attachment loss; B, mild periodontitis with < 2
mm attachment loss and > 3 mm pocket depth; C,
moderate periodontitis with > 2 mm attachment
loss and > 4 mm pocket depth; D, advanced peri-
odontal disease with > 4 mm attachment loss and
> 6 mm pocket depth; E, dental furcation indicative
of severe periodontal disease.
problems, the periodontal indicators were
also individually assessed in separate multi-
variate models. Potential interactions were
explored throughout the modeling process
using multiple-level product terms. 
Results
Data collected from 10,033 participants were
used in this study, corresponding to approxi-
mately 73% of the total number of 20–69-
year-old participants eligible for an exam.
The geometric mean PbB level among the
participants in this study was 2.5 µg/dL
(Table 1). Geometric mean PbB levels were
lower among 20–29-year-old adults com-
pared to 60–69-year-old adults (2.0 µg/dL vs.
3.5 µg/dL). The PbB geometric mean was
greater for men, those who did not graduate
from high school, those in poverty, current
cigarette smokers, residents of older homes,
non-Hispanic blacks, and Mexican Americans.
The PbB geometric mean was also greater for
individuals with periodontal pockets ≥ 5 mm
in depth (3.4 vs. 2.4 µg/dL) and with dental
furcations (3.8 vs. 2.4 µg/dL) compared to
those individuals without those periodontal
conditions. The geometric mean PbB was
incrementally greater as the extent of attach-
ment loss and severity of alveolar bone loss
increased.
The prevalence of individuals with PbB
levels ≥ 10 µg/dL in this study group was
2.36% (Table 1). The remaining demo-
graphic and behavioral factors followed a simi-
lar pattern corresponding to the geometric
mean results. Among persons with periodon-
tal pockets ≥ 5 mm in depth, the prevalence
of PbB levels ≥ 10 µg/dL was 4.46%. If an
individual experienced a dental furcation, the
prevalence of PbB levels ≥ 10 µg/dL was
7.20%. As the extent of attachment loss
increased from < 15% to > 45%, elevated PbB
level prevalence increased from 1.43% to
4.06%. Prevalence ranged from 1.88% to
9.58% as mean alveolar bone loss increased
from < 1.5 mm to ≥ 2.5 mm, indicating a sig-
nificant incremental increase (p < 0.05) that
suggests a potential dose–response relationship
between PbB levels and increasing alveolar
bone loss.
Results from linear regression models are
exhibited in Table 2. Simple (unadjusted)
regression models showed that PbB levels in
20–69-year-old adults were significantly asso-
ciated (p < 0.0.5) with males, increasing age,
lower educational achievement, poverty, his-
tory of cigarette smoking, residing in an older
home, the two minority race/ethnicity
groups, and all four periodontal bone loss
indicators. In a multivariate linear model,
after stepwise regression modeling produced
the most significant main effect covariates
(Model 1), the only periodontal covariate sig-
nificantly associated with PbB levels was the
presence of a dental furcation (p = 0.005).
Poverty was not significantly associated (p >
0.05) with higher PbB levels after adjusting
for effects of periodontal bone loss. After
additional modeling to identify potential
multilevel interactions in a reduced multivari-
ate model with significant risk indicators for
higher PbB levels (Model 2), a significant
interaction emerged between the effects of
smoking status and the presence of a dental
furcation (p = 0.034). The effects of this
interaction were marginal among the remain-
ing social/demographic covariates.
As a result of the smoking and dental fur-
cation interaction, we performed a subanaly-
sis stratified by smoking status. These results
are present in Table 3. The presence of a den-
tal furcation remained significantly associated
with higher PbB levels for both current smok-
ers (p = 0.004) and past smokers (p = 0.015).
However, the presence of dental furcations
was not associated with greater PbB levels
among nonsmokers. The only other signifi-
cant difference observed in the stratified
analysis was that Mexican-American ethnicity
was no longer associated with higher PbB lev-
els for current and former smokers.
Discussion
In this analysis of more than 10,000 persons
representative of the U.S. population 20–69
years of age, we found a strong association
between advanced periodontal bone loss and
higher PbB levels. The finding that moderate
to severe periodontal bone loss defined by the
presence of a dental furcation is associated
with higher PbB levels and that this associa-
tion was not homogenous across the smoking
strata is an important consideration for iden-
tifying higher PbB levels in adults. Moreover,
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Table 1. The weighted geometric mean (GM) PbB levels and the percentage of persons with PbB levels
≥ 10 µg/dL by selected characteristics for the total population.
Characteristic Sample size GM (SE) Percent ≥ 10 µg/dL (SE)
Total 10,033 2.5 (0.08) 2.36 (0.32)
Sex
Femalesa 5,255 1.9 (0.05) 0.66 (0.17)
Males 4,778 3.3 (0.12) 4.06 (0.59)*
Age group (years)
20–29a 3,126 2.0 (0.07) 1.69 (0.42)
30–39 2,805 2.4 (0.09) 2.39 (0.59)
40–49 1,944 2.6 (0.08) 2.12 (0.35)
50–59 1,067 3.2 (0.14) 3.90 (0.91)*
60–69 1,091 3.5 (0.11) 3.27 (0.72)*
Race/ethnicity 
Mexican American 3,390 2.8 (0.08) 4.21 (0.49)*
Non-Hispanic black 2,859 2.8 (0.09) 4.01 (0.47)*
Non-Hispanic whitea 3,352 2.4 (0.09) 2.09 (0.43)
Otherb 432 — —
Education
Did not complete high school 3,357 3.1 (0.11) 5.20 (0.77)*
Completed high schoola 6,619 2.4 (0.07) 1.73 (0.30)
Poverty (federal poverty line)
≤ 130% 2,979 2.6 (0.10) 3.55 (0.59)*
> 130%a 5,989 2.4 (0.07) 2.02 (0.31)
Cigarette smoking status
Current smoker 2,749 3.2 (0.10) 4.57 (0.72)*
Former smoker 2,009 2.6 (0.10) 2.13 (0.51)
Never smokeda 5,274 2.1 (0.06) 1.16 (0.28)
Year home was built
Pre-1946 1,786 2.8 (0.13) 3.89 (0.70)*
1946–1973 4,381 2.5 (0.07) 1.47 (0.24)
Post-1973a 2,743 2.2 (0.10) 1.96 (0.54)
Periodontal pocket probing depth ≥ 5 mm 
Yes 1,072 3.4 (0.13) 4.46 (0.98)*
Noa 8,961 2.4 (0.07) 2.20 (0.31)
Periodontal attachment loss (dentition affected)
0–15%a 4,805 2.1 (0.06) 1.43 (0.32)
16–30% 1,283 2.5 (0.10) 1.41 (0.37)
31–45% 971 2.6 (0.12) 3.58 (1.0)
46–100% 2,759 3.3 (0.11) 4.06 (0.68)*
Mean total bone loss
< 1.5 mma 8,261 2.3 (0.07) 1.88 (0.29)
1.5–2.5 mm 1,256 3.5 (0.14) 3.60 (0.66)*
> 2.5 mm 516 4.5 (0.19) 9.58 (2.4)*
Presence of a dental furcation
Yes 1,174 3.8 (0.17) 7.20 (1.4)*
Noa 8,859 2.4 (0.07) 1.89 (0.28)
aReference category. bPrevalence estimates and SEs are unreliable due to low sample size. *p < 0.05 when compared to
the reference category. 
these findings suggest that preventing the
development of advanced periodontal disease
and promoting smoking cessation may bene-
ficially affect PbB levels. 
The presence of an interaction between
dental furcations and smoking status in the
regression modeling is a significant finding.
Although the effects of smoking on periodon-
tal health have been well reported (Tomar and
Asma 2000), the systemic consequences of
smoking and advanced periodontal disease
have not been described beyond the chronic
inflammatory effects that have been suggested
as potential contributors of coronary heart dis-
ease, atherosclerosis, and cerebrovascular dis-
ease (Arbes et al. 1999; Beck et al. 1996;
Hujoel et al. 2000; Kiechl et al. 2001; Wu et
al. 2000). Furthermore, most studies have
reported only main effect terms, suggesting
that a potential smoking and periodontal dis-
ease interaction is absent when the outcome
under study is a chronic inflammatory disease.
Our results suggest that smoking and advanced
periodontal disease interact qualitatively on
chronic conditions, such as PbB levels, which
potentially may affect systemic health.
Because the presence of dental furcations
is not consistent across all three smoking cate-
gories, our findings indicate that smoking is
not only a confounder in the relationship
between periodontal bone loss and higher
PbB levels but it is a significant effect modi-
fier for this relationship. These findings also
indicate that the effects of smoking status on
PbB levels are not consistent by race/ethnicity
as well. Unlike the presence of dental furca-
tions, Mexican-American ethnicity is not
associated with PbB levels among current and
former smokers, but it is associated with PbB
levels among nonsmokers. These findings
support the notion that nonsmoking or
smoking cessation before the occurrence of
moderate to severe bone loss may have an
important impact on the potential risk for
higher PbB levels.
Dental furcations are an indicator not
only of the severity of bone loss but often of
the magnitude of posterior dental attachment
loss. The length of time required for furcation
development may explain why dental furca-
tions are a stronger indicator for increasing
PbB levels than are attachment loss measures.
It has been reported that significant attach-
ment loss foreruns radiographic bone loss by
6–8 months (Goodson et al. 1984). Thus,
clinical attachment loss measures may also
detect potential pre–bone-loss activity,
whereas dental furcation assessments measure
actual clinical bone loss. 
Another measure of periodontal health,
periodontal pocket depth, was not a signifi-
cant factor for higher PbB levels. Although
pocket depths measuring ≥ 5 mm demon-
strated a significant association with PbB
levels in the univariate analysis, this relation-
ship disappeared when more precise measures
of alveolar bone loss were incorporated into
multivariate analyses. Because pocket depth
measurements are not only influenced by the
degree of bone destruction present but also by
the magnitude of the surrounding soft-tissue
inflammation, these results are biologically
meaningful. Thus, only the portion of bone
loss attributable to the pocket depth measure-
ment would contribute to increased PbB lev-
els. Therefore, compared to attachment loss,
the same magnitude of pocket depth would
have less influence on circulatory blood lead.
In a linear model that included all of the
main effect terms for social/demographic,
behavior, and periodontal bone loss indica-
tors, the only periodontal indicator to remain
significant in a parsimonious model was the
presence of a dental furcation. This finding
may have been influenced by the effects of
multicollinearity among the periodontal bone
loss variables. Results from a correlation
analysis (data not shown) indicated that the
Spearman’s rank correlation coefficient
ranged from 0.35 to 0.57 between the peri-
odontal indicators. Results from a bivariate
analysis showed that 76% of individuals with
dental furcations also had attachment loss
> 45%. In this context, individuals with a
furcation have the most advanced or the more
severe forms of dental bone loss.
Although the effects of increased PbB in
children, as low as 10 µg/dL, have been
widely documented, particularly for cognitive
disabilities and learning disorders, less has
been reported on the effects of PbB levels
≤ 10 µg/dL in adult populations. It has been
reported that lead impedes the biosynthesis of
heme and can increase erythrocyte fatality at
low PbB levels. Hernberg et al. (1971)
reported that at PbB levels <10 µg/dL, δ-
amino levulinic acid dehydratase (ALAD) is
partially inhibited by lead, and at 30 µg/dL,
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Table 2. Linear regression results [coefficients (β), SEs, and p-values] using log PbB levels for the total
population.a
Unadjusted Model 1 Model 2
Characteristic β (SE) p-Value β (SE) p-Value β (SE) p-Value
Sex
Male 0.59 (0.02) 0.000 0.52 (0.02) 0.000 0.52 (0.02) 0.000
Female Reference
Age (years)b 0.01 (0.00) 0.000 0.02 (0.00) 0.000 0.02 (0.00) 0.000
Race/ethnicity
Mexican American 0.14 (0.05) 0.004 0.16 (0.05) 0.002 0.16 (0.05) 0.003
Non-Hispanic black 0.14 (0.04) 0.001 0.20 (0.04) 0.000 0.20 (0.04) 0.000
Non-Hispanic white Reference
Education
Did not complete high school 0.28 (0.03) 0.000 0.14 (0.03) 0.001 0.14 (0.03) 0.000
Completed high school Reference
Poverty (federal poverty line)
≤ 130% 0.07 (0.03) 0.003 — —
> 130% Reference
Cigarette smoking status
Current smoker 0.45 (0.02) 0.000 0.38 (0.02) 0.000 NR
Former smoker 0.25 (0.03) 0.000 0.08 (0.03) 0.011 NR
Never smoked Reference
Year home was built
Pre-1946 0.24 (0.05) 0.000 0.21 (0.05) 0.001 0.21 (0.05) 0.000
1946–1973 0.09 (0.04) 0.031 0.03 (0.04) 0.362 0.03 (0.04) 0.367
Post-1973 Reference
Periodontal pocket probing depth ≥ 5 mm 
Yes 0.35 (0.03) 0.000 — —
No Reference
Periodontal attachment loss (dentition affected)
46–100% 0.47 (0.03) 0.000 — —
31–45% 0.23 (0.04) 0.000 — —
16–30% 0.17 (0.04) 0.000 — —
0–15% Reference
Mean total bone loss
> 2.5 mm 0.66 (0.04) 0.000 — —
1.5–2.5 mm 0.41 (0.03) 0.000 — —
< 1.5 mm Reference
Any furcation present
Yes 0.48 (0.04) 0.000 0.13 (0.05) 0.005 NR
No Reference
Interaction between furcation and smoking — — 0.10 (0.05) 0.034
NR, not reported. A dash (—) indicates that the covariate was not included in the model. 
aSimple (unadjusted) and multivariate (adjusted) linear regression models were used. Model 1 covariates include sex,
age, race/ethnicity, education, smoking, age of home (when built), and dental furcation; Model 2 covariates include sex,
age, race/ethnicity, education, smoking, age of home(when built), dental furcation, and the interaction term for smoking
and dental furcation. bAge was used as a continuous variable.
ALAD inhibition is 50% complete. Suppressive
activity at this enzymatic level reduces
monopyrrole porphobilinogen, the primary
building block for all hemes and vitamin B12
derivatives. Furthermore, Smith et al. (1996)
reported that the effects of lead toxicity may
impede osteoblastic function and that alkaline
phosphatase activity is diminished in a time-
and dose-dependent way. Lead decreases
osteoid formation and increases osteoclastic
activity in rabbits (Hass et al. 1964), decreases
osteoblasts in dogs (Anderson and Danylchuk
1977), and decreases bone density in rats,
which suggests that lead may be a risk factor
for osteopenia (Gruber et al. 1997). Silbergeld
(1991) postulated that endogenous lead
released as a result of accelerated bone metab-
olism during disease or pregnancy and lacta-
tion may be an important risk factor in the
assessment of potential lead toxicity for some
individuals. It was also suggested by Lippman
(1990) that relatively small increases of PbB
levels within the range of 5–30 µg/dL could
have significant effects on elevating blood
pressure in adults.
The mean PbB level among adults in the
United States in 1991–1994 ranged from 2.1
µg/dL in persons 20–49 years of age to 3.4
µg/dL in those ≥ 70 years of age (Pirkle et al.
1998). In a study using endogenous stable
lead isotopes in subjects exposed to low-level,
exogenous sources of lead (1–6 µg/dL PbB
levels), Smith et al. (1996) estimated that
40–70% of lead in blood could be attributed
to skeletal lead release. Consequently, a sig-
nificant fraction of very low lead levels in
blood is representative of normal bone home-
ostasis. With the possibility that normal bone
turnover contributes at least half of the circu-
lating elemental lead, a pathogenic increase in
bone turnover should increase PbB levels as
well. In a recent study, Adachi et al. (1998).
concluded that accelerated bone turnover due
to disease could be associated with lead
resorption and absorption in trabecular bone.
However, the biological processes that under-
lie this association are unclear.
In our analyses, we used demographic
characteristics that are well-known prognostic
indicators for increased PbB levels. The
poverty covariate was initially categorized as
either ≤ 130%, > 130 to < 200%, or ≥ 200%
of the federal poverty level. Because there were
no observed differences in estimates and regres-
sion results between individuals in the two
higher levels, the > 130 to < 200% and the
≥ 200% poverty groups were collapsed into
one group to create a dichotomous poverty cat-
egorical variable. Education was originally cate-
gorized as either having not completed high
school, having graduated from high school, or
having attended college. For reasons similar to
poverty level, the education covariate was rede-
fined as either having not completed high
school or having graduated from high school.
Other potentially important risk factors evalu-
ated, but removed from the final analyses due
to lack of significance, were metropolitan sta-
tus and census region. Occupation was not
included as a covariate because NHANES III
did not sufficiently detail occupational infor-
mation to appropriately classify potential
worker-related exposure to occupational lead.
Furthermore, it is estimated that < 1% of the
employed adults in this data set would have
had occupational exposure to lead; thus, influ-
ences originating from occupational status
should not significantly bias our findings. 
A limitation of our study is the use of a
cross-sectional design to examine indicators
for increased PbB levels, which prevents a
definitive exploration of causality. However,
we believe that the most likely direction for
the observed association indicates that alveo-
lar bone loss promotes increased PbB levels.
Because periodontal disease is a progressively
chronic disorder, and a portion of PbB levels
may be related to prolonged release from the
skeleton, the design of this study does not
effectively address temporal relationships.
Moreover, misclassification of exposure may
have obscured our findings because of our
inability to separate PbB levels from endoge-
nous and exogenous sources. However, a sig-
nificant cohort effect based on exogenous
exposure was not anticipated because our
study was likely limited to adults who experi-
enced elevated environmental lead levels as
children before the beginning of governmen-
tal regulation of lead sources in the United
States in the mid-1970s. Finally, it has been
reported that one-half of mouth examinations
underestimate periodontal disease sites, par-
ticularly the more severe conditions (Ainamo
and Ainamo 1985; Hunt and Fann 1991;
Kingman et al. 1988). Although a limitation
of our study was that the periodontal indica-
tors were derived from a partial mouth exam-
ination, the direction of the bias produced
from underreporting disease may have under-
estimated the magnitude of the association
between periodontal bone loss and PbB. A
strength of our study is its use of a large,
nationally representative sample of adults to
explore and control for multiple risk factors. 
This is the first epidemiologic study to
demonstrate a positive association between
increased PbB levels and clinical parameters
characteristic of bone loss attributed to
advanced periodontal disease. Although prior
experimental studies have described a relation-
ship between PbB levels and bone metabolism
either as a result of disease or normal physio-
logic turnover, our study is the first to explore
intra-oral bone loss as a contributory factor for
higher PbB levels. Although our study design
prevents exploration of causality, our study
promotes the notion that a relationship may
exist between higher PbB levels and bone loss
from periodontal disease, particularly in the
presence of smoking. Our findings also sug-
gest that smoking may act synergistically with
diseased bone to increase PbB levels. Our
analyses suggests that dental furcations have a
similar magnitude of effect on PbB levels
compared to known sociodemographic deter-
minants such as educational attainment and
race/ethnicity. Consequently, severe periodon-
tal bone loss may have important clinical rele-
vance. Because smoking and periodontitis are
mediated by behavioral influences, effective
health promotion and intervention activities
aimed at reducing smoking and improving
oral health may affect PbB levels. Given the
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Table 3. Linear regression results [coefficients (β), SEs, and p-values] stratified by smoking status using
log PbB levels for the total population and controlling for all other independent risk factors.a
Current smoker Former smoker Nonsmoker
(n = 2,317 )b (n = 1,771)b (n = 4,401)b
Characteristic β (SE) p-Value β (SE) p-Value β (SE) p-Value
Sex
Male 0.56 (0.04) 0.000 0.40 (0.05) 0.000 0.55 (0.02) 0.000
Female Reference
Age (years)c 0.02 (0.00) 0.000 0.02 (0.00) 0.000 0.02 (0.00) 0.000
Race/ethnicity
Mexican American 0.09 (0.06) 0.119 0.15 (0.08) 0.068 0.19 (0.05) 0.001
Non-Hispanic black 0.25 (0.05) 0.000 0.24 (0.06) 0.000 0.16 (0.04) 0.001
Non-Hispanic white Reference
Education 
Did not complete high school 0.14 (0.04) 0.002 0.15 (0.07) 0.037 0.14 (0.04) 0.002
Completed high school Reference
Year home was built
Pre-1946 0.15 (0.07) 0.023 0.17 (0.06) 0.009 0.25 (0.07) 0.001
1946–1973 –0.01 (0.05) 0.781 –0.00 (0.04) 0.975 0.08 (0.04) 0.073
Post-1973 Reference
Any furcation present
Yes 0.21 (0.07) 0.004 0.17 (0.07) 0.015 –0.02 (0.07) 0.747
No Reference
aMultivariate linear regression models were used. bTotal observations in the analysis. cAge was used as a continuous
variable.
results of our findings, not only is additional
research needed to further examine and
describe the relationship between periodontal
bone loss and higher PbB levels, but also to
evaluate the health effects of increased PbB
levels in adults.
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